bpc 157 clinical trial BPC-157 and the Difference Between an Evidence Gap and a Cover-Up: What the entire human evidence base actually looks like, and the questions to ask next. — WellFounded This doesn't mean BPC-157 is

Protocol 4: degenerative disc disease and facet arthritis (advanced) Goal: Slow degenerative processes and support tissue quality in chronic spinal degeneration Peptides: BPC-157 : 500mcg twice daily ongoing GHK-Cu : 2mg daily for tissue regeneration KPV : 300mcg daily for anti-inflammatory effects Optional : TB-500 2mg weekly for systemic support Duration: Extended protocols, potentially cycling on and off Why this works: Degenerative conditions require ongoing support rather than acute treatment

Many research laboratories store aliquots between: 20C 80C Lower temperatures significantly slow many degradation processes and help preserve peptide integrity

Find a Chin Up

The math is clean and the measurements are straightforward

Cycling questions dont stop at peptides if youre also using NAD, our guide on how often to take NAD covers the same frequency considerations from the other side